Sontra Medical

Sontra Medical Corporation owns the scientific technology for treatment and diagnostic applications using ultrasound and skin permeation methods, and is developing a non-invasive CTGM for the large diabetes homecare and hospital intensive care markets. Sontra's CTGM device utilizes the FDA-approved SonoPrep® ultrasound-mediated skin permeation system.